BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weber R, Groth C, Lasser S, Arkhypov I, Petrova V, Altevogt P, Utikal J, Umansky V. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Cell Immunol 2021;359:104254. [PMID: 33296753 DOI: 10.1016/j.cellimm.2020.104254] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 . Myeloid-derived suppressor cells: Multi-talented immune suppressive cells that can be either helpful or harmful. Cell Immunol 2021;365:104374. [PMID: 34038759 DOI: 10.1016/j.cellimm.2021.104374] [Reference Citation Analysis]
2 Li C, Zhang Y, Yan S, Zhang G, Wei W, Qi Z, Li B. Alternol triggers immunogenic cell death via reactive oxygen species generation. Oncoimmunology 2021;10:1952539. [PMID: 34350063 DOI: 10.1080/2162402X.2021.1952539] [Reference Citation Analysis]
3 Pimenta DB, Varela VA, Datoguia TS, Caraciolo VB, Lopes GH, Pereira WO. The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia. Front Cell Dev Biol 2021;9:764698. [PMID: 34869355 DOI: 10.3389/fcell.2021.764698] [Reference Citation Analysis]
4 Erin N, Akman M. Effects of in-vitro modulation of TRPV1 activity on immune response of mice bearing metastatic breast carcinoma: Enhanced inflammatory response may hinder therapeutic potentials of TRPV1 agonists. Life Sci 2021;287:120115. [PMID: 34740578 DOI: 10.1016/j.lfs.2021.120115] [Reference Citation Analysis]
5 Ge Y, Cheng D, Jia Q, Xiong H, Zhang J. Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad. Immune Netw 2021;21:e21. [PMID: 34277111 DOI: 10.4110/in.2021.21.e21] [Reference Citation Analysis]
6 Iorio GC, Ammendolia A, Marotta N, Ricardi U, de Sire A. A bond between rheumatic diseases and cancer in the elderly: The interleukin-6 pathway. Int J Rheum Dis 2021. [PMID: 34347374 DOI: 10.1111/1756-185X.14194] [Reference Citation Analysis]
7 Han T, Zuo Z, Qu M, Zhou Y, Li Q, Wang H. Comprehensive Analysis of Inflammatory Response-Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma. Front Pharmacol 2021;12:748993. [PMID: 34712139 DOI: 10.3389/fphar.2021.748993] [Reference Citation Analysis]
8 Suszczyk D, Skiba W, Jakubowicz-Gil J, Kotarski J, Wertel I. The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art. Cells 2021;10:677. [PMID: 33803806 DOI: 10.3390/cells10030677] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Li X, Liu J, Xing Z, Tang J, Sun H, Zhang X, Lv S, Chen Z, Shi M, Chen M, Zuo S, Lyu X, He Y. Polymorphonuclear myeloid-derived suppressor cells link inflammation and damage response after trauma. J Leukoc Biol 2021;110:1143-61. [PMID: 34636072 DOI: 10.1002/JLB.3MA0821-029R] [Reference Citation Analysis]
10 Peisl S, Mellenthin C, Vignot L, Gonelle-Gispert C, Bühler L, Egger B. Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature. PLoS One 2021;16:e0252397. [PMID: 34138876 DOI: 10.1371/journal.pone.0252397] [Reference Citation Analysis]
11 Huang Y, Yi T, Liu Y, Yan M, Peng X, Lv Y. The landscape of tumors-infiltrate immune cells in papillary thyroid carcinoma and its prognostic value. PeerJ 2021;9:e11494. [PMID: 34055497 DOI: 10.7717/peerj.11494] [Reference Citation Analysis]
12 Zeng Y, Xiang Y, Sheng R, Tomás H, Rodrigues J, Gu Z, Zhang H, Gong Q, Luo K. Polysaccharide-based nanomedicines for cancer immunotherapy: A review. Bioact Mater 2021;6:3358-82. [PMID: 33817416 DOI: 10.1016/j.bioactmat.2021.03.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
13 Sugita Y, Yamashita K, Fujita M, Saito M, Yamada K, Agawa K, Watanabe A, Fukuoka E, Hasegawa H, Kanaji S, Oshikiri T, Matsuda T, Nakamura T, Suzuki S, Kakeji Y. CD244+ polymorphonuclear myeloid‑derived suppressor cells reflect the status of peritoneal dissemination in a colon cancer mouse model. Oncol Rep 2021;45:106. [PMID: 33907826 DOI: 10.3892/or.2021.8057] [Reference Citation Analysis]
14 Wang Y, Zhang T, Sun M, Ji X, Xie M, Huang W, Xia L. Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes. Cancers (Basel) 2021;13:5127. [PMID: 34680276 DOI: 10.3390/cancers13205127] [Reference Citation Analysis]
15 Desbois M, Wang Y. Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment. Immunol Rev 2021;302:241-58. [PMID: 34075584 DOI: 10.1111/imr.12982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
16 Naqvi A, MacKintosh ML, Derbyshire AE, Tsakiroglou AM, Walker TDJ, McVey RJ, Bolton J, Fergie M, Bagley S, Ashton G, Pemberton PW, Syed AA, Ammori BJ, Byers R, Crosbie EJ. The impact of obesity and bariatric surgery on the immune microenvironment of the endometrium. Int J Obes (Lond) 2021. [PMID: 34857870 DOI: 10.1038/s41366-021-01027-6] [Reference Citation Analysis]
17 Katongole P, Sande OJ, Nabweyambo S, Joloba M, Kajumbula H, Kalungi S, Reynolds SJ, Ssebambulidde K, Atuheirwe M, Orem J, Niyonzima N. IL-6 and IL-8 cytokines are associated with elevated prostate-specific antigen levels among patients with adenocarcinoma of the prostate at the Uganda Cancer Institute. Future Oncol 2021. [PMID: 34881637 DOI: 10.2217/fon-2021-0683] [Reference Citation Analysis]